Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new paper from the Heather and Tyler groups has uncovered the mechanism responsible for reduced energy in the hearts of patients with type 2 diabetes and revealed a new therapeutic strategy to reverse the energy deficit.

Graphical abstract showing increased energy levels in the heart when mitochondrial deacetylase SIRT3 activator "honokiol" is administered to the diabetic heart, compared to lower levels in the research control group.

Generating exosome subtypes: diverse membrane origins and mergers.

Journal article

Goberdhan DCI. et al, (2026), Trends Cell Biol

Lamination of primary visual cortex in the macaque: Layer 5 subdivisions.

Journal article

Ahmed B. et al, (2026), J Anat

Era of Sugammadex: A Paradigm Shift in Airway Management.

Journal article

Hagberg CA. et al, (2026), Anesthesiology, 144, 978 - 997

Interstitial cells and arrhythmia.

Journal article

Rog-Zielinska EA. et al, (2026), Am J Physiol Cell Physiol, 330, C943 - C953

Multimodal, device-based therapeutic targeting of the cardiovascular autonomic nervous system.

Journal article

Paton JFR. et al, (2026), Nat Rev Cardiol, 23, 255 - 278

Rational discovery of therapeutic PAK1 allosteric activators.

Journal article

He Y. et al, (2026), Cell

Load More